Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer.
We use systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. Our goal is to identify novel targets to generate effective therapies for a range of cancers.
Company Details
- Employees
- 18
- Founded
- 2019
- Address
- 350 Technology Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Pittsburgh, Pennsylvania
Novasenta Questions
Novasenta's LinkedIn profile is https://www.linkedin.com/company/novasenta
Novasenta has
18 employees.
View email and phone details for 18
employees at Novasenta.
Novasenta's industry is
Biotechnology Research
Novasenta's top competitors are
Krystal Biotech, Inc.,
Noveome Biotherapeutics, Inc.,
Peptilogics,
Ariel Precision Medicine,
Spark Therapeutics, Inc.,
Cognition Therapeutics, Inc.,
Carmell Cosmetics,
Avista Therapeutics,
Generian,
Bluesphere Bio.
Novasenta's categories are Biotechnology Research
Novasenta's founding year is 2019
